Abrigana, Arnel S.
HRN: 25-78-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2024
MUPIROCIN 2%, 15G (TUBE)
08/29/2024
09/05/2024
TOPICAL
Thin Strip
BID
7 Days
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes